Verrica Pharmaceuticals logo

Verrica Pharmaceuticals share price today

(VRCA)

Verrica Pharmaceuticals share price is $0.68 & ₹58.17 as on 30 Dec 2024, 20.30 hrs IST

$0.68

0.04

(5.49%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Verrica Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Verrica Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Verrica Pharmaceuticals. Get details on the Indian mutual funds that are investing in Verrica Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Verrica Pharmaceuticals's financials.

Verrica Pharmaceuticals share price movements

  • Today's Low: $0.62
    Today's High: $0.69

    Day's Volatility :9.96%

  • 52 Weeks Low: $0.61
    52 Weeks High: $11.41

    52 Weeks Volatility :94.65%

Verrica Pharmaceuticals Returns

PeriodVerrica Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-52.81%
-9.8%
0.0%
6 Months
-91.39%
-4.7%
0.0%
1 Year
-89.95%
1.9%
0.0%
3 Years
-92.53%
-1.8%
-21.3%

Verrica Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$0.684
Open
$0.64
Today's High
$0.6888
Today's Low
$0.6202
Market Capitalization
$62.0M
Today's Volume
$1.0M
52 Week High
$11.41
52 Week Low
$0.6109
Revenue TTM
$9.2M
EBITDA
$-73.4M
Earnings Per Share (EPS)
$-1.84
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2059.89%

How to invest in Verrica Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Verrica Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Verrica Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Verrica Pharmaceuticals or VRCA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Verrica Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Verrica Pharmaceuticals shares which would translate to 1.258 fractional shares of Verrica Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Verrica Pharmaceuticals, in just a few clicks!

Returns in Verrica Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Verrica Pharmaceuticals investment value today

Current value as on today

₹12,780

Returns

₹87,220

(-87.22%)

Returns from Verrica Pharmaceuticals Stock

₹90,015 (-90.01%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Verrica Pharmaceuticals

-51.75%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Investment in Verrica Pharmaceuticals from India has reduced in the last 30 days as on Dec 30, 2025. -51.75% less purchase transactions for Verrica Pharmaceuticals in the last 30 days versus the previous period.

-45%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Verrica Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 30, 2025. -45% less investors are searching Verrica Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Verrica Pharmaceuticals

  • Perceptive Advisors LLC

    7.84%

  • Vanguard Group Inc

    1.42%

  • BlackRock Inc

    1.25%

  • FMR Inc

    0.70%

  • State Street Corp

    0.57%

  • Geode Capital Management, LLC

    0.50%

Analyst Recommendation on Verrica Pharmaceuticals

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Verrica Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Verrica Pharmaceuticals

What analysts predicted

Upside of 831.37%

Current:

$0.68

Target:

$6.33

Insights on Verrica Pharmaceuticals

  • Price Movement

    In the last 7 days, VRCA stock has moved down by -2.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 5.17M → -1.78M (in $), with an average decrease of 134.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -17.18M → -22.86M (in $), with an average decrease of 33.0% per quarter
  • VRCA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.3% return, outperforming this stock by 115.0%
  • VRCA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.1% return, outperforming this stock by 131.9%
  • Price to Sales

    ForVRCA every $1 of sales, investors are willing to pay $3.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Verrica Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Verrica Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Verrica Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Verrica Pharmaceuticals Inc
-46.54%
-91.39%
-89.95%
-92.53%
-95.52%
Regeneron Pharmaceuticals, Inc.
-6.55%
-32.6%
-21.28%
12.81%
90.81%
Biontech Se
-2.77%
44.55%
1.43%
-55.8%
195.97%
Alnylam Pharmaceuticals, Inc.
-5.94%
-2.2%
22.08%
40.33%
105.82%
Vertex Pharmaceuticals Incorporated
-12.23%
-13.26%
-0.52%
86.14%
86.27%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Verrica Pharmaceuticals Inc
NA
NA
NA
-1.46
-20.6
-0.71
NA
-0.75
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.07
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Verrica Pharmaceuticals Inc
Buy
$62.0M
-95.52%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
90.81%
17.67
33.61%
Biontech Se
Buy
$27.3B
195.97%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.3B
105.82%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.8B
86.27%
32.84
-4.51%

About Verrica Pharmaceuticals

verrica pharmaceuticals inc., a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the united states. the company's lead product candidate include vp-102 that is in phase iii clinical trial for the treatment of molluscum contagiosum; in phase ii clinical trial for the treatment of common warts; and completed phase i clinical trial for the treatment of genital warts. it is also developing cantharidin-based product candidate, vp-103 for the treatment of plantar warts. the company has a license agreement with lytix biopharma as to develop and commercialize ltx-315 for dermatologic oncology indications. verrica pharmaceuticals inc. was founded in 2013 and is headquartered in west chester, pennsylvania.
Organization
Verrica Pharmaceuticals
Employees
100
CEO
Mr. Christopher G. Hayes
Industry
Health Technology

Management People of Verrica Pharmaceuticals

NameTitle
Mr. Christopher G. Hayes
Chief Legal Officer, Secretary, Chief Compliance Officer & General Counsel
Dr. Jayson M. Rieger M.B.A., Ph.D.
President, CEO & Director
Mr. John J. Kirby CPA
Interim CFO
Dr. Gary Goldenberg M.D.
Chief Medical Officer
Mr. Eugene Scavola
Executive Vice President of Technical Operations
Dr. Bradley J. Catalone MBA, Ph.D.
Head of Drug Development

Important FAQs about investing in Verrica Pharmaceuticals from India :

What is Verrica Pharmaceuticals share price today?

Verrica Pharmaceuticals share price today stands at $0.68, Open: $0.64 ; Previous Close: $0.65 ; High: $0.69 ; Low: $0.62 ; 52 Week High: $11.41 ; 52 Week Low: $0.61. The stock opens at $0.64, after a previous close of $0.65. The stock reached a daily high of $0.69 and a low of $0.62, with a 52-week high of $11.41 and a 52-week low of $0.61.

Can Indians buy Verrica Pharmaceuticals shares?

Yes, Indians can invest in the Verrica Pharmaceuticals (VRCA) from India.

With INDmoney, you can buy Verrica Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Verrica Pharmaceuticals at zero transaction cost.

How can I buy Verrica Pharmaceuticals shares from India?

It is very easy to buy Verrica Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Verrica Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Verrica Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Verrica Pharmaceuticals stocks?

To start investing in Verrica Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Verrica Pharmaceuticals

Today’s highest price of Verrica Pharmaceuticals (VRCA) is $0.69.

Today’s lowest price of Verrica Pharmaceuticals (VRCA) is $0.62.

What is today's market capitalisation of Verrica Pharmaceuticals

Today's market capitalisation of Verrica Pharmaceuticals VRCA is 62.0M

What is the 52 Week High and Low Range of Verrica Pharmaceuticals

  • 52 Week High

    $11.41

  • 52 Week Low

    $0.61

What are the historical returns of Verrica Pharmaceuticals?

  • 1 Month Returns

    -46.54%

  • 3 Months Returns

    -91.39%

  • 1 Year Returns

    -89.95%

  • 5 Years Returns

    -95.52%

Who is the Chief Executive Officer (CEO) of Verrica Pharmaceuticals

Mr. Christopher G. Hayes is the current Chief Executive Officer (CEO) of Verrica Pharmaceuticals.